NO317293B1 - Tetrahydrobenzindolderivat, farmasoytisk preparat samt mellomproduktforbindelse - Google Patents

Tetrahydrobenzindolderivat, farmasoytisk preparat samt mellomproduktforbindelse Download PDF

Info

Publication number
NO317293B1
NO317293B1 NO20003285A NO20003285A NO317293B1 NO 317293 B1 NO317293 B1 NO 317293B1 NO 20003285 A NO20003285 A NO 20003285A NO 20003285 A NO20003285 A NO 20003285A NO 317293 B1 NO317293 B1 NO 317293B1
Authority
NO
Norway
Prior art keywords
mmol
tetrahydro
compound
synthesis example
group
Prior art date
Application number
NO20003285A
Other languages
English (en)
Norwegian (no)
Other versions
NO20003285D0 (no
NO20003285L (no
Inventor
Masao Koyama
Chika Kikuchi
Osamu Ushiroda
Takashi Ando
Kazuyuki Fuji
Masayo Okuno
Eriko Morita
Masako Imai
Toyokazu Hiranuma
Original Assignee
Meiji Seika Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP35838197A external-priority patent/JPH11189585A/ja
Application filed by Meiji Seika Kaisha filed Critical Meiji Seika Kaisha
Publication of NO20003285D0 publication Critical patent/NO20003285D0/no
Publication of NO20003285L publication Critical patent/NO20003285L/no
Publication of NO317293B1 publication Critical patent/NO317293B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/90Benzo [c, d] indoles; Hydrogenated benzo [c, d] indoles
    • C07D209/92Naphthostyrils
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Indole Compounds (AREA)
NO20003285A 1997-12-25 2000-06-22 Tetrahydrobenzindolderivat, farmasoytisk preparat samt mellomproduktforbindelse NO317293B1 (no)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP35838197A JPH11189585A (ja) 1997-12-25 1997-12-25 5−ht7受容体結合能を有するテトラヒドロベンズインドール誘導体
JP35838097 1997-12-25
JP8591398 1998-03-31
JP13687298 1998-05-19
JP22970998 1998-08-14
JP31933698 1998-11-10
PCT/JP1998/005827 WO1999033804A1 (fr) 1997-12-25 1998-12-22 Derives de tetrahydrobenzindole

Publications (3)

Publication Number Publication Date
NO20003285D0 NO20003285D0 (no) 2000-06-22
NO20003285L NO20003285L (no) 2000-08-23
NO317293B1 true NO317293B1 (no) 2004-10-04

Family

ID=27551662

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003285A NO317293B1 (no) 1997-12-25 2000-06-22 Tetrahydrobenzindolderivat, farmasoytisk preparat samt mellomproduktforbindelse

Country Status (12)

Country Link
US (1) US6498251B1 (zh)
EP (1) EP1057814B1 (zh)
JP (1) JP4459437B2 (zh)
KR (1) KR100588249B1 (zh)
CN (1) CN1129578C (zh)
AT (1) ATE290527T1 (zh)
CA (1) CA2316388C (zh)
DE (1) DE69829317T2 (zh)
DK (1) DK1057814T3 (zh)
ES (1) ES2238778T3 (zh)
NO (1) NO317293B1 (zh)
WO (1) WO1999033804A1 (zh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6407112B1 (en) * 1998-04-22 2002-06-18 Meiji Seika Kaisha, Ltd. Optically active tetrahydrobenzindole derivative
UA69420C2 (uk) * 1998-10-06 2004-09-15 Янссен Фармацевтика Н.В. ТРИЦИКЛІЧНІ <font face="Symbol">D3</font>-ПІПЕРИДИНИ ЯК <font face="Symbol">a<sub></font>2</sub>-АНТАГОНІСТИ
GB9828004D0 (en) * 1998-12-18 1999-02-10 Smithkline Beecham Plc Use
AU1025601A (en) * 1999-10-18 2001-04-30 Smithkline Beecham Plc Tetrahydrobenzindolone derivatives, their preparation and their use as 5-ht7 receptor antagonists
AR035417A1 (es) * 2001-01-27 2004-05-26 Hoffmann La Roche Derivados triciclicos de lactama y sultama, procesos para su elaboracion, medicamentos que los contienen, y el uso de dichos compuestos en la preparacion de medicamentos
WO2004018432A1 (en) * 2002-08-20 2004-03-04 Eli Lilly And Company Substituted azepines as histamine h3 receptor antagonists, preparation and therapeutic uses
WO2005012310A1 (ja) * 2003-08-04 2005-02-10 Soda Aromatic Co.,Ltd. チエノピリジン系化合物の香料における使用、および新規チエノピリジン系化合物
NZ551543A (en) * 2004-05-11 2009-12-24 Egis Gyogyszergyar Nyrt Pyridine derivatives of alkyl oxindoles as 5-HT7 receptor active agents
DE602006012650D1 (de) * 2005-04-26 2010-04-15 Hypnion Inc Benzisoxazolpiperidinverbindungen und verfahren zu deren anwendung
EP2054416B8 (en) * 2006-08-04 2014-07-16 Merz Pharma GmbH & Co. KGaA Substituted pyrazolopyrimidines, a process for their preparation and their use as medicine
EP1956006A1 (en) 2007-02-06 2008-08-13 Laboratorios del Dr. Esteve S.A. Heterocyclyl-substituted-tetrahydro-naphthalen derivatives as 5-HT7 receptor ligands
EP1975161A1 (en) * 2007-03-28 2008-10-01 Laboratorios del Dr. Esteve S.A. Heterocyclyl-substituted- tetrahydro-napthalen-amine derivatives, their preparation and use as medicaments
US8338447B2 (en) 2008-03-24 2012-12-25 Medivation Technologies, Inc. Pyrido[3,4-B]indoles and methods of use
EP2480079A4 (en) * 2009-09-23 2015-04-08 Medivation Technologies Inc PYRIDO- (3,4-B-) INDOLE AND USE METHOD THEREFOR
CN108623585B (zh) * 2018-05-22 2021-07-09 中国人民解放军第二军医大学 β-四氢咔啉类抗真菌药物及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69733427T2 (de) 1996-06-28 2006-04-27 Meiji Seika Kaisha Ltd. Tetrahydrobezindol derivate
US6407112B1 (en) 1998-04-22 2002-06-18 Meiji Seika Kaisha, Ltd. Optically active tetrahydrobenzindole derivative

Also Published As

Publication number Publication date
KR100588249B1 (ko) 2006-06-13
ES2238778T3 (es) 2005-09-01
WO1999033804A1 (fr) 1999-07-08
DE69829317D1 (de) 2005-04-14
EP1057814B1 (en) 2005-03-09
NO20003285D0 (no) 2000-06-22
CN1286683A (zh) 2001-03-07
US6498251B1 (en) 2002-12-24
DE69829317T2 (de) 2006-04-06
CA2316388A1 (en) 1999-07-08
JP4459437B2 (ja) 2010-04-28
KR20010033609A (ko) 2001-04-25
NO20003285L (no) 2000-08-23
DK1057814T3 (da) 2005-07-04
EP1057814A1 (en) 2000-12-06
ATE290527T1 (de) 2005-03-15
CA2316388C (en) 2009-09-08
EP1057814A4 (en) 2001-07-11
CN1129578C (zh) 2003-12-03

Similar Documents

Publication Publication Date Title
CA2615403C (en) Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
NO317293B1 (no) Tetrahydrobenzindolderivat, farmasoytisk preparat samt mellomproduktforbindelse
JP3531169B2 (ja) 縮合ヘテロ環化合物およびその医薬用途
US20040138230A1 (en) Heterocyclic substituted piperazines for the treatment of schizophrenia
US20100152177A1 (en) Compounds having 5-ht6 receptor affinity
TWI483946B (zh) 5-ht受體調節劑及其使用方法
KR20090114439A (ko) 아실구아니딘 유도체
US20080200471A1 (en) 6&#39; substituted compounds having 5-ht6 receptor affinity
US20080318941A1 (en) 4&#39; substituted compounds having 5-ht6 receptor affinity
JP2007517014A (ja) N−置換ピペリジン及びピペラジン誘導体
NO129043B (zh)
SK285594B6 (sk) Gama-karbolín, spôsob jeho prípravy a kompozícia s jeho obsahom
CA2797019C (en) Modulators of 5-ht receptors and methods of use thereof
NO311515B1 (no) Tetrahydrobenzindolforbindelser, og farmasöytiske preparater inneholdende slike forbindelser
CA2617473A1 (en) Acylguanidine derivative or salt thereof
US6407112B1 (en) Optically active tetrahydrobenzindole derivative
WO1996024594A1 (fr) Derives de benzodiazepines, sels issus de ces derives, et medicaments a base de ces derives et sels
KR100539724B1 (ko) 항정신병성약제로서의헥사하이드로-피리도(4,3-b)인돌유도체
AU2012202570B2 (en) Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
JP2021119130A (ja) 縮環ラクタム誘導体からなる医薬

Legal Events

Date Code Title Description
ERR Erratum

Free format text: TETRAHYDROBENZINDOLDERIVAT, FARMASOYTISK PREPARAT SAMT MELLOMPRODUKTFORBINDELSE

MM1K Lapsed by not paying the annual fees